サルコペニア(Sarcopenia)の治療薬パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Sarcopenia Overview 7
Therapeutics Development 8
Pipeline Products for Sarcopenia – Overview 8
Pipeline Products for Sarcopenia – Comparative Analysis 9
Sarcopenia – Therapeutics under Development by Companies 10
Sarcopenia – Therapeutics under Investigation by Universities/Institutes 11
Sarcopenia – Pipeline Products Glance 12
Clinical Stage Products 12
Early Stage Products 13
Sarcopenia – Products under Development by Companies 14
Sarcopenia – Products under Investigation by Universities/Institutes 15
Sarcopenia – Companies Involved in Therapeutics Development 16
Calzada Limited 16
Cytokinetics, Inc. 17
GlaxoSmithKline plc 18
Myos Corporation 19
Neurotune AG 20
Novartis AG 21
PsiOxus Therapeutics, Ltd. 22
Regeneron Pharmaceuticals, Inc. 23
Sumitomo Dainippon Pharma Co., Ltd. 24
Sarcopenia – Therapeutics Assessment 25
Assessment by Monotherapy Products 25
Assessment by Target 26
Assessment by Mechanism of Action 28
Assessment by Route of Administration 30
Assessment by Molecule Type 32
Drug Profiles 34
AOD-9604 – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
bimagrumab – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
CK-2066260 – Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
MT-102 – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
NEP-28 – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
NT-1654 – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Protein for Musculoskeletal Disorders – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
Recombinant Protein for Sarcopenia – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
REGN-1033 – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
S-107 – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
Small Molecules to Inhibit Furin for Sarcopenia and Cachexia – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
Small Molecules to Inhibit JAK3 for Sarcopenia and Cachexia – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
Sarcopenia – Recent Pipeline Updates 50
Sarcopenia – Dormant Projects 53
Sarcopenia – Discontinued Products 54
Sarcopenia – Product Development Milestones 55
Featured News & Press Releases 55
Mar 13, 2012: Calzada Announces Positive Results Of AOD9604 In Cartilage And Muscle Repair Models 55
Dec 14, 2011: Calzada Announces New Applications For AOD9604 55
Dec 08, 2011: PsiOxus Therapeutics To Present Data On MT-102 At Cachexia Conference 56
Aug 02, 2011: Researchers At Columbia University Discover New Drug For Sarcopenia 57
Dec 16, 2010: Myotec Therapeutics Completes Merger With Hybrid BioSystems To Form PsiOxus Therapeutics 58
Appendix 60
Methodology 60
Coverage 60
Secondary Research 60
Primary Research 60
Expert Panel Validation 60
Contact Us 61
Disclaimer 61